1 |
Ame J, Spenlehauer C, De Murcia G. The PARP superfamily. BioEssays 26:882-893 (2004)
DOI
|
2 |
Bakondi E, Bai P, Erdelyi K, Szabo C, Gergely P, Virag L. Cytoprotective effect of gallotannin in oxidatively stressed HaCaT keratinocytes: the role of poly(ADP-ribose) metabolism. Exp. Dermatol. 13:170-178 (2004)
DOI
|
3 |
Bakondi E, Bai P, Szabo E, Hunyadi J, Gergely P, Szabo C, et al. Detection of poly(ADP-ribose) polymerase activation in oxidatively stressed cells and tissues using biotinylated NAD substrate. J. Histochem. Cytochem. 50:91-98 (2002)
DOI
|
4 |
Bouchard VJ, Rouleau M, Poirier GG. PARP-1, a determinant of cell survival in response to DNA damage. Exp. Hematol. 31:446-454 (2003)
DOI
|
5 |
Cosi C. New inhibitors of poly(ADP-ribose)polymerase and their potential therapeutic targets. Expert Opin. Ther. Pat. 12:1047-1071 (2002)
DOI
|
6 |
Hong SJ, Dawson TM, Dawson VL. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol. Sci. 25:259-264 (2004)
DOI
|
7 |
Ikejima M, Noguchi S, Yamashita R, Ogura T, Sugimura T, Gill D, et al. The zinc fingers of human poly(ADP-ribose) polymerase are differentially required for the recognition of DNA breaks and nicks and the consequent enzyme activation. J. Biol. Chem. 265:21907-21913 (1990)
DOI
|
8 |
Jagtap P, Szabo C. Poly(ADP-ribose)polymerase and the therapeutic effects of its inhibitors. Nat. Rev. Drug Discov. 4:421-440 (2005)
DOI
|
9 |
Keung MY, Wu Y, Vadgama JV. PARP inhibitors as a therapeutic agents for homologous recombination deficiency in breast cancers. J. Clin. Med. 8:435 (2019)
DOI
|
10 |
Matulonis UA. PARP inhibitors in BRCA-related ovarian cancer-and beyond! [cited 2019 June 4]. Available from: https://www.ascopost.com/issues/november-25-2017/parp-inhibitors-in-brca-relatedovarian-cancer-and-beyond/ (2017)
|
11 |
Nassiri-Asl M, Hosseinzadeh H. Review of the pharmacological effects of Vitis vinifera (Grape) and its bioactive constituents: an update. Phytother. Res. 30:1392-1403 (2016)
DOI
|
12 |
Nicoletti VG, Stella AMG. Role of PARP under stress conditions: cell death or protection? Neurochem. Res. 28:187-194 (2003)
DOI
|
13 |
Perez-Lopez F, Haya J, Chedraui P. Vaccinium macrocarpon: An interesting option for women with recurrent urinary tract infections and other health benefits. J. Obstet. Gynaecol. Res. 35:630-639 (2009)
DOI
|
14 |
Szabo C, Pacher P, Zsengeller Z, Vaslin A, Komjati K, Benko R, et al. Angiotensin II-mediated endothelial dysfunction: Role of poly(ADP-ribose)polymerase activation. Mol. Med. 10:28-35 (2004)
DOI
|
15 |
Tu S, Chen L, Ho Y. An apple a day to prevent cancer formation: reducing cancer risk with flavonoids. J. Food Drug Anal. 25:119-124 (2017)
DOI
|
16 |
Wolfe K, Wu X, Liu RH. Antioxidant Activity of Apple Peels. J. Agr. Food Chem. 51:609-614 (2003)
DOI
|